NL-OMON26715招募中不适用
A phase II study to assess engraftment and engraftment kinetics after double cord blood transplantation with a reduced-intensity conditioning regimen in patients eligible for allogeneic stem cell transplantation lacking a matched unrelated donor.
Erasmus Medical Centre RotterdamDepartment of Hematology0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 18-65 years inclusive.
- •2. Meeting the criteria for a MUD allo SCT and high risk disease.
排除标准
- •1. Relapse APL.
- •2. Primary myelofibrosis.
研究者
相似试验
已完成
2 期
A phase II study to assess engraftment and engraftment kinetics after double cord blood transplantation with a reduced-intensity conditioning regimen in patients eligible for allogeneic stem cell transplantation lacking a matched unrelated donor.Cancer of bone marrow10024324Acute LeukemiaNL-OMON35273HOVO40
进行中（未招募）
不适用
A phase II study to assess engraftment and engraftment kinetics after double cord blood transplantation with a reduced-intensity conditioning regimen in patients eligible for allogeneic stem cell transplantation lacking a matched unrelated donor - engraftment after double cord blood transplantatioEUCTR2008-000053-35-NLErasmus MC40
招募中
1 期
Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic LeukemiaB-cell NHLCLLNCT05869279Fondazione Matilde Tettamanti Menotti De Marchi Onlus29
已完成
2 期
Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain CancerMetastatic Brain CancerNCT00525590Eisai Inc.69
招募中
1 期
A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Majorβ-thalassemiaNCT06465550Shanghai BDgene Co., Ltd.9